Treatment of chronic hepatitis C with PEGylated interferon and ribavirin
- 1 February 2002
- journal article
- review article
- Published by Springer Nature in Current Gastroenterology Reports
- Vol. 4 (1) , 23-30
- https://doi.org/10.1007/s11894-002-0034-y
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis CHepatology, 2001
- Ribavirin and interferon alpha-2b combination treatment of chronic hepatitis C is effective in patients with clotting disordersGastroenterology, 2001
- Paroxetine for the Prevention of Depression Induced by High-Dose Interferon AlfaNew England Journal of Medicine, 2001
- Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis CBioconjugate Chemistry, 2001
- Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter studyHepatology, 2000
- Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic viewGastroenterology, 1999
- EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus StatementJournal of Hepatology, 1999
- 10-year follow-up after interferon-α therapy for chronic hepatitis CHepatology, 1998
- Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfaHepatology, 1997